Progress in the application of 177Lu- and 225Ac-targeted radionuclide therapy in pancreatic ductal adenocarcinoma
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, characterized by the limited efficacy of current therapies and an urgent need for novel treatment strategies. Targeted radionuclide therapy (TRT) enables the selective deliver... ...
